Evidence map›Paper›PMID 37097724›Full record

ArticleJournal of medical Internet research2023

Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study.

Benli Su, Yu Chen, Xingping Shen, Jianchao Guo, Yuchen Ding, Xiao Ma, Yuxin Yang, Dongfang Liu

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Benli Su *Department of Endocrinology, The Second Hospital of Dalian Medical University, Dalian, China.ORCID 0000-0001-9804-9950
Yu Chen *Department of Endocrinology, The Second Hospital of Tianjin Medical University, Tianjin, China.ORCID 0009-0000-3135-9911
Xingping Shen *Department of Endocrinology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.ORCID 0000-0003-0747-2265
Jianchao GuoDepartment of Endocrinology, The Second Hospital of Tianjin Medical University, Tianjin, China.ORCID 0009-0006-1616-8053
Yuchen DingLilly Suzhou Pharmaceutical Co Ltd, Shanghai, China.ORCID 0000-0001-9062-8923
Xiao MaLilly Suzhou Pharmaceutical Co Ltd, Shanghai, China.ORCID 0000-0001-8835-2286
Yuxin YangLilly Suzhou Pharmaceutical Co Ltd, Shanghai, China.ORCID 0000-0003-3765-9493
Dongfang LiuDepartment of Endocrinology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.ORCID 0000-0002-8801-2190
Lilly (China) · CNDalian Medical University · CNSecond Hospital of Tianjin Medical University · CNZhongshan Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) is a worldwide public health concern. Mobile health management platforms could be a potential way to achieve effective glycemic control.

objectiveThis study aimed to evaluate the real-world effectiveness of the Lilly Connected Care Program (LCCP) platform in glycemic control among patients with T2DM in China.

methodsThis retrospective study included Chinese patients with T2DM (aged ≥18 years) from April 1, 2017, to January 31, 2020, for the LCCP group and from January 1, 2015, to January 31, 2020, for the non-LCCP group. Propensity score matching was used to match the LCCP and non-LCCP groups to reduce confounding, with covariates including age, sex, the duration of diabetes, baseline hemoglobin A

resultsA total of 923 patients were included, among whom 303 pairs of patients were well matched after propensity score matching. HbA

conclusionsThe LCCP mobile platform was effective in glycemic control among patients with T2DM in China in the real world.

Indexed as

Diabetes Mellitus, Type 2AdolescentAdultBlood GlucoseHumansHypoglycemic AgentsInsulinRetrospective StudiesBlood GlucoseHypoglycemic AgentsInsulindiabetes managementhemoglobin A1cLCCPLilly Connected Care Programreal-word studyT2DMtype 2 diabetes mellitus

Identifiers

PMID37097724
PMCPMC10170357
OpenAlexW4360973112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.